Purpose: Thyroid cancer incidence has been increasing for several decades, but the reasons are not fully understood. Previous surveillance reports have covered less than 26% of the U.S. population. More recent, nationwide data are needed. This study examines thyroid cancer incidence among younger women by age, race/ethnicity, geography, and tumor size. Patients and Methods: Our study uses nationwide surveillance data to describe incidence rates and recent trends in thyroid cancer among adults aged 20-39 years in the United States during 1999-2007, with a focus on females. Results: Incidence rates were more than five times higher among females (16.4 per 100,000; 95% confidence interval [CI]: 16.2-16.6) than among males (3.1 per 100,000; 95% CI: 3.1-3.2). Among females, rates were higher among non-Hispanic whites than among other racial/ethnic groups and higher in the Northeast compared with other regions ( p < 0.05). During 1999-2007, incidence rates increased 5.3% each year among females (95% CI: 4.7-5.9). This increase was observed across five-year age groups, racial/ethnic groups (except American Indians/Alaska Natives), geographic regions, and tumor sizes. Conclusion: The increase in rates across all tumor sizes suggests that the observed increases cannot be attributed solely to changes in diagnostics or surveillance. In addition, the continued increase in incidence rates in recent years among persons born after 1960 suggests that other, more contemporary factors than those previously proposed may play a contributing role.
Introduction
T he increase in the incidence of thyroid cancer in the United States during the past 30 years has been documented in numerous reports. [1] [2] [3] [4] [5] [6] [7] Incidence rates have been consistently higher among women than among men for several decades, and this difference has increased over time. 1, 2, 4, 5 In 2007, more than 35 ,000 people in the United States were diagnosed with thyroid cancer, and approximately onequarter of them were younger than 40 years of age. 8 Although survival rates following a diagnosis of thyroid cancer are high (as evidenced by low mortality), the treatment and management of thyroid cancer can have long-term effects on survivors' health and quality of life. [8] [9] [10] [11] The American Thyroid Association recommends a near-total or total thyroidectomy for tumors more than a centimeter in diameter, and recommends radioactive iodine ablation in addition to surgery for high-risk patients and those with distant metastases. 9 Given improvements in diagnosis and treatment, there is the possibility that some thyroid cancers are being overdiagnosed. 12 The U.S. Preventive Services Task Force does not currently recommend for or against routine screening for thyroid cancer in asymptomatic adults, and there is little evidence that treatment in those without symptoms leads to improved clinical outcomes. 13, 14 After treatment, survivors require lifelong thyroid hormone replacement therapy 10 and may have an increased risk for cancers of the salivary gland, stomach, colorectal, breast, prostate, kidney, brain/central nervous system, bone, and adrenal glands, as well as soft tissue sarcoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia (standardized incidence ratio for all second primary malignancies = 1.2; 95% CI: 1.17-1.24). 15 Additionally, the risk for future cancers may be greater for those diagnosed at a young age. 16 The reasons for the increase in thyroid cancer incidence are not well understood, but several theories have been proposed.
Changes to coding practices and improvements in diagnostics during the 1970s are thought to play a role in the reported increase in incidence. 17 Among other proposed explanations is the use of medical radiation to treat benign thyroid disease, a practice that occurred from the 1920s to the 1950s. 18 However, the impact of the introduction of newer diagnostic technology and the discontinued use of medical radiation to treat benign thyroid disease would be expected to diminish over time, and thus other factors may be contributing to the continued increase in incidence during recent years, especially among young adults.
Examining incidence rates and recent trends over time among persons born during or after 1960 can aid progress toward understanding more contemporary risk factors for thyroid cancer and may ultimately help identify opportunities for primary prevention. 19 Previous studies have analyzed surveillance data from the National Cancer Institute's (NCI) Surveillance, Epidemiology and End Results (SEER) program and have only covered up to 26% of the U.S. population. [3] [4] [5] 7, 20 As a result, these studies were limited in their ability to examine geographic variation or trends at younger ages (when incidence rates are lowest). More recent, nationwide data are needed. The current study enhances previous research by using combined data from the Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries (NPCR) and NCI's SEER, which provides greater geographic and regional coverage and greater statistical stability. The purpose of this study is to use nationwide surveillance data to look specifically at recent trends in thyroid cancer among young adults aged 20-39 years in the United States, focusing on females by age, race/ethnicity, U.S. census region, and tumor stage, histology, and size.
Materials and Methods

Data sources
Data from the two federal cancer surveillance programs, CDC's NPCR and NCI's SEER, were used to examine thyroid cancer incidence rates and trends. 8, 21, 22 Both NPCR and SEER data were collected and reported using standard data items and uniform codes and procedures, as documented by the North American Association of Central Cancer Registries. 23 Combined NPCR and SEER data that meet high quality data standards are published yearly in the United States Cancer Statistics (USCS) report and represent official federal statistics on cancer. 8, 24 Only cancer incidence data that meet publication criteria for the USCS report were included in this analysis. 25 The use of combined NPCR/SEER data maximized the population coverage for the analysis. 
Statistical analysis
Incidence rates were calculated per 100,000 persons and were age-adjusted to the 2000 U.S. standard population. 31 Given the low case counts among those below the age of 20, the final analyses were limited to those aged 20-39 years. Combined NPCR/SEER data for 2003-2007 were used to calculate age-specific incidence rates by sex and age-specific rates for females by age Annual percent change (APC) was calculated by using the least squares method, and 95% confidence intervals (95% CI) were based on the Gamma method and used the Tiwari modification (Tiwari mod). 32 Combined NPCR/SEER data for 1999-2007 were used to calculate APC by sex and to calculate APC for females by age, race/ethnicity, U.S. census region, U.S. state, tumor stage, and tumor histology. SEER data for 1999-2007 were used to calculate APC for females by tumor size. Cancer cases with unknown sex or age were excluded from all analyses. The categories used for race/ethnicity were mutually exclusive. Differences between groups, when noted, are statistically significant at p < 0.05. All statistical analyses were conducted with SEER*Stat (version 6.5.2). 33 
Results
Thyroid cancer incidence rates increased significantly over time among young adults aged 20-39 years during 1999-2007. Rates were consistently higher and increased more rapidly over time among females compared to rates among males ( Fig. 1) . Among females, rates increased an average of 5.3% (95% CI: 4.7-5.9) each year; among males, rates increased an average of 3.8% (95% CI: 3.2-4.8) each year. The absolute change in rates among males was only 1.0 per 100,000, compared to an absolute increase of 6.6 per 100,000 among females. By 2007, rates were more than five times higher among young females (18.4 per 100,000) than among young males (3.6 per 100,000). (Table 1) . Incident thyroid cancers were distributed across different tumor sizes: 29.1% were less than or equal to 1 centimeter, 30.4% were 1.1-2.0 centimeters, and 32.3% were 2.1-5.0 centimeters. Only 3.5% of tumors were more than 5.0 centimeters. Rates increased significantly over time across all tumor sizes, including those more than 5.0 centimeters in size (Table 1) . Furthermore, there was no significant difference in APC when stratifying by tumor size.
Significant differences in rates and trends over time were observed by demographic characteristics (Table 1) . Rates were highest among those aged 35-39 years compared to other age groups; the largest percentage increase in rates over time occurred in this age group as well. The lowest rates were among ages 20-24 years. Significant differences were also observed across different racial/ethnic groups, with the highest rates among non-Hispanic whites. The percentage increase in rates over time was not significantly different across racial/ethnic groups. When stratifying by geographic region, the highest rates and APCs of thyroid cancer were seen in the Northeast compared to the other regions. This trend held true for all racial/ethnic groups except for AI/AN ( Table 2 ). The South had the lowest rates overall compared to the other regions (Table 1 ), but this pattern was not consistent across the different racial/ethnic groups ( Table 2 ). Rates and APCs were also computed for each U.S. state to determine if any states were outliers within their given region. There was modest variation by state, but there were no notable outliers within each region (data not shown).
Rates were consistently higher among those aged 35-39 years compared to other five-year age groups across all racial/ethnic groups, except AI/AN (Table 3) , but APCs did not always follow this pattern. Among non-Hispanic whites, those aged 35-39 years had the highest APC compared to other age groups. In all other racial/ethnic groups, APCs were not significantly different across five-year age groups. The pattern of rates increasing with age and over time was consistent across all four geographic regions (Table 4) .
Discussion
The results from this study indicate that incidence rates for thyroid cancer have continued to increase in recent years among young adults of both sexes in the United States. In less than a decade, rates have increased more than 50%, with no indication that the rate of increase is slowing or leveling off. The difference in rates by sex has also continued to grow over time. Other notable differences were observed among young women by five-year age group, geographic region, and race/ ethnicity. The observation of higher incidence rates among older age groups is consistent with previous literature, which has shown that thyroid cancer incidence rates typically peak around ages 40-59 among women. 4, 5 Reasons for geographic differences in incidence rates are largely unknown and could be due to multiple factors. A study using California Cancer Registry data from 1988-2004 found that Japanese women born outside the United States had a significantly higher rate of thyroid cancer than U.S.-born Japanese women, but among Chinese and Filipina women the U.S.-born women had higher rates. 34 One possible reason for geographic differences in incidence rates could be differences in geographic-specific exposures early in life.
In the current study, rates increased among most racial/ ethnic groups and within all geographic regions of the United States. However, non-Hispanic white women consistently had the highest rates, followed by API and Hispanic women. A recent study using SEER data observed similar racial/ethnic patterns in thyroid cancer incidence across all age groups. 35 The use of combined NPCR/SEER data allowed us to provide additional information about these racial/ethnic patterns, including a more detailed age breakdown and a description of the racial/ethnic patterns in each geographic region.
Another notable finding was the increase in the incidence of thyroid tumors of all sizes. Some researchers have proposed that the observed increases are not caused by increases in actual disease but are artifacts of changes in diagnosis and surveillance. 3 For example, improvements in diagnostic techniques, such as the use of ultrasound and thin needle aspiration, have led to an increased ability to detect earlystage cancers, and the coding rules for thyroid cancer were changed in 1988 to include benign-appearing papillary lesions, thus widening the definition of papillary thyroid cancer. 3, 6, [36] [37] [38] If earlier changes in diagnostics and surveillance were the sole reasons for the observed increases, one would expect to observe increases in the rates of only small thyroid tumors and a leveling off of the rate of increase over time, unless physicians are becoming more aggressive in their screening practices over time. However, the increase in rates is occurring across all tumor sizes. 1, 4, 7, 35 Our study results indicate similar trends specifically among younger women, with no indication that the rate of increase is slowing, 
THYROID CANCER AMONG YOUNGER WOMEN
suggesting that other factors are contributing to the observed increases.
One possible cause for the observed increase in thyroid cancer among young adults is increasing exposure to ionizing radiation, the most well-established risk factor for thyroid cancer. [39] [40] [41] Common sources of exposure to ionizing radiation in the United States include medical imaging procedures and natural sources of radiation such as radon. 42 Researchers have estimated that the per capita dose of radiation from medical exposure (not including dental or radiotherapy) increased almost 600% (approximately 3.0 millisieverts) from 1982 to 2006, with the increase largely being attributed to increased use of computed tomography (CT) scans and nuclear medicine. 42 Pediatric diagnostic procedures are among the most rapidly increasing groups of CT procedures. 43, 44 Children are more sensitive to radiation than adults and have a longer window of opportunity for expressing radiation damage. 44, 45 Dental x-rays are another common source of radiation exposure. Although radiation doses are relatively low, a recent case-control study found that exposure to dental x-rays was significantly associated with an increased risk of thyroid cancer. 46 Some have also suggested that the increase in thyroid cancer may be in part caused by increases in environmental exposures to chemicals that can interfere with normal thyroid function. [47] [48] [49] [50] [51] For example, perchlorate, nitrate, thyocyante, polychlorinated biphenyls (PCBs), bisphenol A (BPA), polybrominated diphenyl ether (PBDE), and phthalates are all thought to alter thyroid function in some manner. [47] [48] [49] [50] [51] [52] [53] Perchlorate, phthalate metabolites, and BPA have been detected in measurable amounts in urinary samples, and PCBs and PBDEs have been detected in measurable amounts in serum samples from the U.S. population across all age groups. 54 PBDEs have been measured in breast milk from donors in Texas at levels many times higher than levels measured in women in Europe. 55 Rates of thyroid cancer also tend to be lower in European countries than in the United States, particularly among white women. 
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The higher incidence rates and more dramatic increases in rates over time among young women compared to young men suggest that reproductive or hormonal factors could play a role in the etiology of thyroid cancer. 2, 56 However, the evidence for a relationship between reproductive and hormonal factors and thyroid cancer has been inconsistent. [56] [57] [58] Women tend to be more susceptible than men to thyroid diseases and to the thyroid-disrupting effects of certain chemicals, particularly while pregnant. 52, 59, 60 Therefore, changes in environmental risk factors, such as an increasing prevalence of endocrine disruptors in the environment, would be expected to have a greater effect on the thyroid health of women than of men.
During the past 30 years, the prevalence of obesity has increased among young men and women, and this increase has been suggested as a potential explanation for the rise in incident thyroid cancer. 57, 61, 62 However, the association between these metabolic factors and thyroid cancer has been inconsistent and still needs further exploration. 57 The most recent data on obesity in the United States suggest that the increase in rates of obesity is slowing, particularly among women. 61 If obesity is a contributing factor there may be a lagged effect, with subsequent changes in thyroid cancer rates occurring years later.
This study provides a unique contribution to the current literature on thyroid cancer by closely examining recent thyroid cancer incidence rates, trends, and disparities among younger women in the United States. This study benefits from the use of combined NPCR/SEER data, and is the first study to examine incidence rates of thyroid cancer using data that cover approximately 90% or more of the U.S. population, allowing for the comparison of rates and trends by U.S. census region and by demographic subpopulations. This focused approach may further inform plausible hypotheses for contemporary causes of thyroid cancer and reasons for the marked increase in incidence rates in recent years. The study does have some limitations. Given the ecological design of this study, conclusions about the causes of the observed trends cannot be made. Although it is plausible that the risk factors described above may play a role, better information about the exposure history of persons with thyroid cancer is needed before such hypotheses can be substantiated. This study is also limited by the usual concerns related to registry data, such as the potential for incomplete data collection and inconsistencies in tumor coding. Rates of thyroid cancer among AI/AN may be underestimated in this study due to potential misclassification of race in central cancer registries. 63 In conclusion, thyroid cancer incidence rates have increased substantially among younger women in the United States in recent years. Rates were significantly higher among non-Hispanic white women compared to other racial/ethnic groups and significantly higher among women living in the Northeast compared to other geographic regions. These descriptive patterns in incidence among this more recent birth cohort may help inform hypotheses about factors currently contributing to the incidence of thyroid cancer in the United States.
